RE: Vote Success7 Dec 2024 20:58
Micky a placing is an investment, the difference is when you go to the UK there is no money, there is no liquidity or inward investment into AIM or microcap Main Market. Its dead, what retail money is available flows through companies like Peterhouse, but its a very small pot. Every placing is paid for by existing shareholders or traders, its never a "NEW investment", its a trader who is already a shareholder who wants to sell their existing holding to buy back cheaper in a placing, or its a trader who wants to short sell pre-rns or forward sell after. It has NEVER been majority investment, it would have been much better if Hemo had just sold the shares themselves directly to the market.
Thats the point of this consolidation, there is money in the US, there are investors who will invest in Hemogenyx, especially now there are people who will invest in a clinical company to gamble on positive results. People who are not going to flip, not going to short or forward sell. THIS is the turning point when we FINALLY get rid of the leeches of LSE. Its no surprise they are out in their droves because this change will drive them nuts, they have had years of easy pickings attacking and trading hemo and now? No market soundings, no forward warnings of investment, no shorting by placees, no dump of cheap shares, none of it. The company think they have something, investors believe them and they have said:
NOT WHEN YOU ARE A PENNY STOCK. And so we consolodate.